Malignant thymoma (MT) is a rare tumor that is often associated with myasthenia gravis (MG). This tumor is considered resistant to chemotherapy. We had the opportunity to treat five patients with MT with cyclophosphamide 800 mg/m2, Adriamycin 50 mg/m2, and vincristine 1.4 mg/m2 (CAV) in cycles of 21
β¦ LIBER β¦
Myasthenia gravis, paraneoplastic pemphigus and thymoma, a rare triade
β Scribed by D. T. Winkler; P. Strnad; M. L. Meier; S. Roten; P. Went; P. Lyrer; A. J. Steck
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 253 KB
- Volume
- 254
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Chemotherapy in thymoma and myasthenia g
β
P. A. Kosmidis; E. Iliopoulos; S. Pentea
π
Article
π
1988
π
John Wiley and Sons
π
English
β 519 KB
Thymoma with myasthenia gravis in a dog
β
G. A. Hall; J. Mcc. Howell; D. G. Lewis
π
Article
π
1972
π
John Wiley and Sons
π
English
β 506 KB
Eosinophilia, myositis, and myasthenia g
β
Irit Avni; Yehonatan Sharabi; Menachem Sadeh; Aron S. Buchman
π
Article
π
2006
π
John Wiley and Sons
π
English
β 67 KB
π 1 views
Myasthenia gravis with thymoma and autoi
β
N. Tuncer Elmaci; S. Ratip; D. Δ°nce-GΓΌnal; T. TanridaΔ
π
Article
π
2003
π
Springer Milan
π
English
β 36 KB
Ryanodine receptor autoantibodies in mya
β
Dr Γ
se Mygland; Ole-BjΓΈrn Tysnes; Johan A. Aarli; Nils Erik Gilhus; Roald Matre;
π
Article
π
1992
π
John Wiley and Sons
π
English
β 357 KB
π 1 views
The characteristics of thymoma with myas
β
Yasumasa Monden; Tadashi Uyama; Toshikatu Taniki; Jumpei Hashimoto; Yoshitaka Fu
π
Article
π
1988
π
John Wiley and Sons
π
English
β 334 KB
Of 134 patients with thymoma, 79 (59%) also had myasthenia gravis (MG). The thymoma with MG differed from that in the absence of MG in the following aspects: The ratio of lymphocytes to epithelial cells in the tumor was larger, the polygonal cell type was more prominent (i.e., in 83% of the MG patie